medical-blog
Last updated: 2018-07-30

Fukuoka Cancer Comprehensive Clinic: Apheresis Technology and Advanced Lymphocyte Immunotherapy

S
Medical Supporter Team
Cross-border medical coordination and editorial review team
Fukuoka Cancer Comprehensive Clinic: Apheresis Technology and Advanced Lymphocyte Immunotherapy

Fukuoka Cancer Comprehensive Clinic: Advanced Apheresis and Cell Therapy

Medical Supporter — Information Notice

This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.

Any specific treatment plan must be assessed by a licensed physician in Japan

Fukuoka Cancer Comprehensive Clinic is one of the medical institutions that Medical Supporter works with. Led by Dr. Takashi Morisaki, who has clinical research experience at Kyushu University Hospital, the clinic provides immune cell therapy as an adjunct treatment for advanced cancer; suitability is assessed by a physician.

Two Core Technology Platforms

Advanced Apheresis Technology: Unlike standard whole blood collection, the clinic employs precision component apheresis systems. Immune cells (T cells, NK cells) are selectively extracted via blood separator technology, with plasma and red cells immediately returned to the patient.

Advantage: Sufficient cellular material obtained in single procedure, reducing phlebotomy burden in weakened patients.

In-House CPC Laboratory: To reduce the risk of cell damage during transport, the clinic has an on-site Cell Processing Center (CPC).

Quality Management: Culture can begin shortly after apheresis, with the aim of maintaining cell viability.

Treatment Modalities

Activated Lymphocyte Therapy: Synchronized T cell and NK cell expansion

Dendritic Cell Vaccine (DC): Tumor-specific antigen presentation strategy

Peptide Vaccine Combinations: Personalized HLA-matched peptide therapy

Data Source

Fukuoka Cancer Comprehensive Clinic Clinical Program

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Considering medical care in Japan? Need information and support?

We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free (initial direction only; further services are quoted separately); an advisor will help you clarify the next steps.

Fukuoka HQ: +81-92-984-3200
Formerly officially certified, No. B-066

Related Reading